Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 19 Sep 2026

Advent International announced that it entered into a definitive agreement with Yatharth Hospitals to invest Rs 3,150 crore of primary capital to acquire a significant minority stake of 24.9% in the latter.

5 publishers have reported this development. Each act of reporting is below, cited.

The record

Advent International announced that it entered into a definitive agreement with Yatharth Hospitals to invest Rs 3,150 crore of primary capital to acquire a significant minority stake of 24.9% in the latter.

indiatimes.com18 Sep 2026

Advent International entered into a definitive agreement with Yatharth Hospital & Trauma Care Services to invest ₹3,150 crore for a 24.9 per cent stake through a primary capital infusion.

Global private equity investor Advent International is investing Rs 3,150 crore in Yatharth Hospital & Trauma Care Services for a 24.9% stake.

Global private equity firm Advent International will invest ₹3,150 crore in Yatharth Hospital and Trauma Care Services Ltd for a 24.9% stake in the company.

livemint.com17 Sep 2026

Global private equity investor Advent International will invest Rs 3,150 crore of primary capital in Yatharth Hospital and Trauma Care Services for a 24.9% stake.

indiatimes.com17 Sep 2026

Yatharth Hospital & Trauma Care Services is in discussions with Advent International for a potential fund infusion of up to Rs 3,000 crore.

moneycontrol.com15 Sep 2026

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.